Research & Development

FDA Grants Breakthrough Status to EvoLiver for Liver Cancer Detection
Research & Development FDA Grants Breakthrough Status to EvoLiver for Liver Cancer Detection

Could a simple blood test radically change how liver cancer is detected, especially for those at high risk? This question resonates strongly with recent developments in cancer diagnostics, notably with the FDA's recognition of EvoLiver™, a groundbreaking innovation by Mursla Bio. This d

Tina Knowles' Cancer Journey Highlights Importance of Regular Screenings
Research & Development Tina Knowles' Cancer Journey Highlights Importance of Regular Screenings

Tina Knowles’ personal experience with breast cancer serves as a powerful reminder of the critical importance of regular screenings. When Knowles missed her mammogram appointments for four years, it led to a delayed diagnosis of stage 1A breast cancer. Her story underscores the life-saving p

How Does Fructose Fuel Cancer Growth?
Research & Development How Does Fructose Fuel Cancer Growth?

Fructose, a common sugar found in many everyday foods, has been discovered to indirectly contribute to the growth of tumors. This potentially transformative finding opens new avenues for cancer treatment. Building upon early twentieth-century research by German physiologist Otto Warburg, which

Can Stem Cell Therapy Transform Parkinson's Disease Treatment?
Research & Development Can Stem Cell Therapy Transform Parkinson's Disease Treatment?

Parkinson's disease, a progressive and degenerative brain condition, affects more than 1 percent of individuals over the age of 60 worldwide, leading to symptoms such as slow movements, muscle tremors, stiffness, and difficulty walking. Traditional treatments focus primarily on managing

Pharmacogenomics: Enhancing Safety in Cancer Treatment
Research & Development Pharmacogenomics: Enhancing Safety in Cancer Treatment

In the dynamic world of modern medicine, expectations run high for treatments that are not only effective but also minimize risks. Yet, conventional cancer therapies often walk a fine line between disease eradication and severe side effects. What if there was a way to tailor treatments to each

CROs Shift to Alternative Methods Following FDA Animal Testing Phase-Out
Research & Development CROs Shift to Alternative Methods Following FDA Animal Testing Phase-Out

Chinese contract research organization GemPharmatech has expanded its presence in the United States with a new facility in San Diego, announced on April 17. The facility is designed for laboratories and housing genetically engineered mouse models, aimed at enhancing their capabilities in offering

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later